| __timestamp | Incyte Corporation | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 511495000 | 28203205 |
| Thursday, January 1, 2015 | 753751000 | 99892000 |
| Friday, January 1, 2016 | 1105719000 | 133591000 |
| Sunday, January 1, 2017 | 1536216000 | 154937000 |
| Monday, January 1, 2018 | 1881883000 | 164246000 |
| Tuesday, January 1, 2019 | 2158759000 | 175338000 |
| Wednesday, January 1, 2020 | 2666702000 | 198321000 |
| Friday, January 1, 2021 | 2986267000 | 227490000 |
| Saturday, January 1, 2022 | 3394635000 | 212018000 |
| Sunday, January 1, 2023 | 3695649000 | 145238000 |
| Monday, January 1, 2024 | 4241217000 |
Data in motion
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Incyte Corporation has demonstrated a remarkable trajectory, with its annual revenue surging by over 620% from 2014 to 2023. Starting at approximately $511 million in 2014, Incyte's revenue reached nearly $3.7 billion by 2023, showcasing its robust market presence and strategic advancements.
In contrast, Travere Therapeutics, Inc. experienced a more modest growth, with its revenue increasing by around 415% over the same period. Despite starting at a lower base of approximately $28 million in 2014, Travere's revenue peaked at about $227 million in 2021 before slightly declining in 2023.
This comparison highlights the dynamic nature of the biotech industry, where strategic innovation and market adaptation are crucial for sustained growth and competitiveness.
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Incyte Corporation?
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Breaking Down Revenue Trends: Incyte Corporation vs BioMarin Pharmaceutical Inc.
Incyte Corporation vs Exelixis, Inc.: Examining Key Revenue Metrics
Revenue Insights: Incyte Corporation and Bausch Health Companies Inc. Performance Compared
Revenue Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Incyte Corporation or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Incyte Corporation and Geron Corporation: A Comprehensive Revenue Analysis
Who Generates More Revenue? Incyte Corporation or Taro Pharmaceutical Industries Ltd.
Ascendis Pharma A/S vs Travere Therapeutics, Inc.: Examining Key Revenue Metrics
MorphoSys AG vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Supernus Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?